ClinicalTrials.gg
DrugRead study by study

Orforglipron clinical trials

Also written LY3502970.

studies test it
53
open now
12
in phase 3
27
first study started
2019
ClinicalTrials.gov finds 53 studies for orforglipron. How that becomes 53 here

Every study that search finds has been read, to see whether and how it gives orforglipron. ClinicalTrials.gov counts as of Nov 16, 2026. How drug pages count

  1. 53Found by its intervention search · See all 53 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 36 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. +1Give it under a name that search misses: a biosimilar’s code or a misspelling
  3. 54Give orforglipron to participants
  4. −1Compare another treatment with it
  5. 53Test it: the count on this site

Get an email when these change. Save the orforglipron studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Orforglipron
35

Development codes

LY3502970
46

Studies by the year they started

53 studies that test it; most in 2023 (13)

Studies that test orforglipron, by start year
YearStudies
20191
20201
20216
20224
202313
202410
202511
20267

By phase

A phase 1/2 study counts in both.

Phase 1
21
Phase 2
3
Phase 3
27
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 50 · Other 3

Eli Lilly and Company (50) · Massachusetts General Hospital (2) · University of Florida (1)

Often tested with

Tested in the same studies.

Simvastatin (1) · Digoxin (1) · Acetaminophen (1) · Semaglutide (1) · Tirzepatide (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8, 8 in phase 3

Studies that test orforglipron, phase 3 first.

Studies

Open first, then newest update. How each study uses orforglipron has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 53

See all 53 studies that test orforglipron →

Tested on its own · 44 — no other medicine in its arm

Showing 20 of 44. See all 44 →

Tested with established drugs · 6 — they are given beside it
Tested in a combination · 3 — another drug in the study is under test too
As the comparator · 1 — what is tested is compared with orforglipron

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call orforglipron · ClinicalTrials.gg INT002055

  • MeSH (NLM) C000729680orforglipronConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 7ZW40D021MORFORGLIPRONConfirmed FDA, NLM, Wikidata
  • Wikidata Q120491908orforglipronConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C199084OrforglipronOne source FDA
  • DrugBank DB18964One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion